NRP1 and cancer: Because originally NRP1 has been established as a key regulator in EC of VEGFA signalling, many approaches have been used to inhibit NRP1 binding to VEGFA as a potential therapeutic target to prevent angiogenesis in cancer and neovascular eye diseases.